News
Purchase price of $47 per share in cash represents an equity value of approximately $3.9 billion, or an enterprise value of ...
Germany’s Merck KGaA has agreed to acquire U.S. biotech SpringWorks Therapeutics for $3.9 billion. The acquisition, aimed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results